Birdwatch Note Rating
2023-03-15 21:08:51 UTC - NOT_HELPFUL
Rated by Participant: 4A27520EE411DEC876F4D77139A3E2979FE3D4A46800669FDC69FBFDA5FE79AE
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details